Archives
AHA: Baxdrostat Studied in Treatment-Resistant Hypertension
Dose-dependent reductions in systolic blood pressure seen in phase 2 dose-ranging study
AHA: Lowering TGs With Pemafibrate Does Not Cut CV Risk in T2DM
In patients with T2DM, hypertriglyceridemia, and low HDL cholesterol levels, the risk for cardiovascular events was not lower with pemafibrate versus placebo
AHA: Environmental Exposures Tied to CVD Deaths in the U.S., U.K.
Risk-attributable cardiovascular death rate associated with lead exposure higher in the U.S. than the U.K.; opposite pattern seen between the countries for particulate matter exposure
AHA: Vaping Tied to Negative Effects on Cardiovascular Function
Increases in BP, heart rate greater; reduction in brachial artery diameter greater; and performance on exercise parameters worse for vapers, smokers compared with controls
AHA: Those With, at Risk for CVD Less Likely to Use Wearables
Wearable health device use in the U.S. lower among those older than 65 years, higher among those with higher household income, educational attainment
AHA: Heart Disease Death Rates in U.S. Spiked in 2020
Following steady decline from 2010 to 2019, death rates increased in 2020, especially among young adults, non-Hispanic Blacks
AHA: Once-Daily Edoxaban Seems Safe for Pediatric Cardiac Patients
Rates of clinically relevant bleeding similar between groups receiving edoxaban or standard-of-care anticoagulation
Once-Weekly Semaglutide Cuts BMI for Teens With Obesity
Greater reduction in BMI seen for semaglutide plus lifestyle intervention versus lifestyle intervention alone
ASA: Preoperative Cannabis Use Tied to Higher Pain After Surgery
However, no significant differences seen in opioid use postoperatively between cannabis users and nonusers
ASA: Green Light Therapy for Pain-Related Anxiety Studied in Fibromyalgia
Small study suggests green light therapy might reduce anxiety in patients with fibromyalgia who are taking opioids for chronic pain
